These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
137 related items for PubMed ID: 31188963
1. Continuous Intravenous Inotropes in Ward Units: Expanding Therapy Outside Intensive Care using a Safety-Oriented Protocol. Hastenteufel LCT, Clausell N, Neyeloff JL, Domingues FB, Caballero LG, Silva ERRD, Goldraich LA. Arq Bras Cardiol; 2019 Jun 06; 112(5):573-576. PubMed ID: 31188963 [Abstract] [Full Text] [Related]
2. Ambulatory Intravenous Inotropic Support and or Levosimendan in Pediatric and Congenital Heart Failure: Safety, Survival, Improvement, or Transplantation. Apostolopoulou SC, Vagenakis GA, Tsoutsinos A, Kakava F, Rammos S. Pediatr Cardiol; 2018 Oct 06; 39(7):1315-1322. PubMed ID: 29777282 [Abstract] [Full Text] [Related]
12. Long-term intravenous inotropes in low-output terminal heart failure? von Scheidt W, Pauschinger M, Ertl G. Clin Res Cardiol; 2016 Jun 15; 105(6):471-81. PubMed ID: 26879807 [Abstract] [Full Text] [Related]
13. Positive inotropic drug infusions for patients with heart failure: current controversies and best practice. Gorski LA. Home Healthc Nurse; 2002 Apr 15; 20(4):244-53; quiz 253-4. PubMed ID: 11984193 [Abstract] [Full Text] [Related]
14. Safety and clinical utility of long-term intravenous milrinone in advanced heart failure. Mehra MR, Ventura HO, Kapoor C, Stapleton DD, Zimmerman D, Smart FW. Am J Cardiol; 1997 Jul 01; 80(1):61-4. PubMed ID: 9205021 [Abstract] [Full Text] [Related]
15. [Combination therapy; dobutamine and milrinone]. Kato M, Hirayama A. Nihon Rinsho; 2011 Nov 01; 69 Suppl 9():428-33. PubMed ID: 22724242 [No Abstract] [Full Text] [Related]
19. Milrinone in advanced heart failure: dose and therapeutic monitor outside intensive care unit. Charisopoulou D, Leaver N, Banner NR. Angiology; 2014 Apr 15; 65(4):343-9. PubMed ID: 23620310 [Abstract] [Full Text] [Related]
20. Effects of standard heart failure therapy and concomitant treatment with intravenous furosemide or inotropes (dobutamine, dopamine, and/or milrinone) on renal function and mortality in patients treated with nesiritide. Kurien S, Warfield KT, Wood CM, Miller WL. Am J Cardiol; 2006 Dec 15; 98(12):1627-30. PubMed ID: 17145223 [Abstract] [Full Text] [Related] Page: [Next] [New Search]